09.12.2012 Views

q 2006 by Taylor & Francis Group, LLC - Developers

q 2006 by Taylor & Francis Group, LLC - Developers

q 2006 by Taylor & Francis Group, LLC - Developers

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Active Targeting Strategies in Cancer with a Focus on Potential Nanotechnology Applications 27<br />

well as nanoparticle size for some routes of administration. Recent studies have called into question<br />

the safety of repeated aerosolized exposure of carbon nanomaterials, 66 and nanoparticles have been<br />

shown to have a higher inflammatory potential per given mass than do larger particles. 57 Such<br />

particles may provide an efficient means to actively target lung cancers that is facilitated <strong>by</strong> the<br />

natural properties of these materials. In general, safety issues related to using nanoparticles to target<br />

cancers for treatment and diagnosis will be specific for the material used to prepare the particle: its<br />

size, the type of targeting mechanism it utilizes, its fate at the targeted site, and its non-targeted<br />

distribution and elimination pattern from the body.<br />

3.4 TARGETING TO CANCER CELLS<br />

In a very simplified sense, cancers occur through dysregulation of normal cell function. The body is<br />

designed to correct tissue defects following damage, to expand selected immune cells in response to<br />

a pathogen, and to compensate for perceived deficiencies in one cell type <strong>by</strong> altering the phenotype<br />

of another such as in stem cell recruitment. Each of these processes is mediated <strong>by</strong> (normally)<br />

regulated events that allow cells to lose their differentiated phenotype with restrained growth<br />

characteristics and acquire a replication-driven phenotype. A lack of re-differentiation into a<br />

growth-restrained, differentiated phenotype is the paradigm of cancer. Repair of an epithelial<br />

wound is a good example of this phenomenon (Figure 3.3). It is the lack of re-differentiation<br />

and continued responsiveness of these cells to growth factors and growth activators that supports<br />

and maintains the cancer phenotype. Extensive genomic differences between differentiated and<br />

non-differentiated forms of the same cell account for the differences observed between these two<br />

cell phenotypes. 67<br />

(a)<br />

(b)<br />

(c)<br />

(d)<br />

Growth<br />

factors<br />

Cell division<br />

FIGURE 3.3 Loss and recovery of barrier function associated with normal epithelia. (a) Epithelia express tight<br />

junctions ( ) and associate at their base with a complex of proteins known as the basement membrane<br />

( ). (b) Damage to epithelia increases responses to growth factors and results in differentiated epithelial<br />

cells that can freely divide. (c) Cell division continues until damaged area is covered. (d) Cell–cell contacts<br />

such as adherens junctions, tight junctions, and gap junctions have been shown to suppress growth and<br />

stimulate re-differentiation.<br />

q <strong>2006</strong> <strong>by</strong> <strong>Taylor</strong> & <strong>Francis</strong> <strong>Group</strong>, <strong>LLC</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!